Clinical Trials on Human-animal Interaction in New Zealand
Total 1336 results
-
Daiichi Sankyo, Inc.CompletedEffect of Pexidartinib on the Way the Body Processes CYP3A4 and CYP2C9 Substrates (Pharmacokinetics)Drug Interaction PotentialUnited States, New Zealand, Taiwan, Netherlands
-
Sumitomo Pharma America, Inc.CompletedDrug-drug InteractionsUnited States
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Alios Biopharma Inc.Completed
-
Gilead SciencesCompleted
-
VaxartCompletedSeasonal Influenza BNew Zealand
-
Gilead SciencesCompletedHepatitis C Virus InfectionNew Zealand
-
Enanta Pharmaceuticals, IncNovotech (Australia) Pty LimitedCompletedHepatitis CNew Zealand
-
Assembly BiosciencesCompletedChronic Hepatitis BNew Zealand
-
Yale UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...Not yet recruitingContraception | Pharmacogenomic Drug InteractionUnited States
-
Janssen Research & Development, LLCTerminatedHealthy | Hepatitis B, ChronicNew Zealand
-
Ventrus Biosciences, IncTKL Research, Inc.CompletedCLARITHROMYCIN/DILTIAZEM [VA Drug Interaction]United States
-
Hoffmann-La RocheCompletedHepatitis C, Chronic, Healthy VolunteerNew Zealand
-
Novartis PharmaceuticalsTerminated
-
LEO PharmaCompletedDrug Interaction PotentiationGermany
-
Gilead SciencesCompletedChronic Hepatitis CNew Zealand
-
Max Zeller Soehne AGUnknownDrug Interaction StudyGermany
-
Gilead SciencesCompleted
-
Repros Therapeutics Inc.CompletedDrug InteractionsUnited States
-
Qilu Pharmaceutical Co., Ltd.Unknown
-
Assembly BiosciencesCompletedChronic Hepatitis BNew Zealand
-
Arbutus Biopharma CorporationRecruitingChronic Hepatitis bNew Zealand
-
Antipodean Pharmaceuticals, Inc.Completed
-
Arrowhead PharmaceuticalsTerminated
-
Vertex Pharmaceuticals IncorporatedCompletedHepatitis C | Chronic Hepatitis C | HCV | CHCNew Zealand
-
Assembly BiosciencesCompleted
-
Enanta Pharmaceuticals, IncTerminatedChronic Hepatitis B Virus InfectionNew Zealand
-
Alios Biopharma Inc.TerminatedHepatitis B | Chronic Hepatitis B | Viral Hepatitis BNew Zealand
-
Gilead SciencesCompleted
-
Novira Therapeutics, Inc.CompletedChronic Hepatitis BNew Zealand
-
Gilead SciencesCompletedChronic Hepatitis C InfectionNew Zealand
-
Virion TherapeuticsRecruitingChronic Hepatitis BHong Kong, New Zealand
-
Aligos TherapeuticsTerminatedChronic Hepatitis BUnited Kingdom, New Zealand
-
Arrow TherapeuticsDDS, Dundee; David Mutimer, Birmingham; Ed Gane, ACS New ZealandTerminatedChronic Hepatitis CNew Zealand, United Kingdom
-
NovartisNovartis PharmaceuticalsCompletedHepatitis BHong Kong, Singapore, New Zealand
-
Soroka University Medical CenterEiger BioPharmaceuticalsActive, not recruitingHepatitis D, ChronicIsrael, New Zealand, Turkey
-
Hoffmann-La RocheCompletedHepatitis C, ChronicNew Zealand, Poland, France
-
Hoffmann-La RocheCompletedHepatitis C, ChronicNew Zealand, Australia
-
Gilead SciencesCompletedChronic Hepatitis BUnited States, New Zealand
-
Hoffmann-La RocheCompletedHepatitis B, ChronicNew Zealand
-
Eiger BioPharmaceuticalsCompletedHepatitis D, ChronicIsrael, New Zealand, Pakistan
-
Hoffmann-La RocheTerminatedHepatitis B, ChronicHong Kong, Taiwan, New Zealand
-
Arbutus Biopharma CorporationCompletedHepatitis B, ChronicAustralia, New Zealand
-
Macfarlane Burnet Institute for Medical Research...St Vincent's Hospital MelbourneCompletedHepatitis CAustralia, New Zealand
-
Janssen, LPCompletedHIV Infections | CryptosporidiosisUnited States
-
Janssen, LPCompletedHIV Infections | CryptosporidiosisUnited States
-
Stolle Milk Biologic InternationalCompletedHIV Infections | CryptosporidiosisUnited States
-
Kirby InstituteCompletedDAA-based Therapy for Recently Acquired Hepatitis C II (DAA = Directly Acting Antiviral) (DARE-C II)Hepatitis CAustralia, New Zealand